Cure My Disease

Don't miss your cure!

 Log in / Sign up

MS and fertility: new study looks at ovarian health in young women

NCT ID NCT07164924

Completed Knowledge-focused Sponsor: University Hospital, Clermont-Ferrand Source: ClinicalTrials.gov ↗

First seen Jun 26, 2026 · Last updated Jun 26, 2026

Summary

This study looked at whether multiple sclerosis (MS) and its treatments affect a woman's egg supply. Researchers measured a hormone called AMH in blood samples from over 800 women with MS or a related condition. The goal was to see if disease activity or medications impact ovarian reserve, which is key for fertility. The findings could help guide decisions about fertility preservation.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to
If successful, this study could help doctors better counsel women with MS about their fertility and when to consider fertility preservation.
What could go wrong
This is an observational study, not a treatment trial. It cannot prove cause and effect, and results may not apply to all patients.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for FERTILITY are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

infertility disorder multiple sclerosis neuromyelitis optica

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

FERTILITY MULTIPLE SCLEROSIS NEUROMYELITIS OPTICA SPECTRUM DISORDERS

Contacts and locations

Locations

  • AP-HM

    Marseille, France

  • AP-HP - Créteil

    Créteil, France

  • CHI Poissy- Saint-Germain-en-Laye

    Poissy, France

  • CHU Amiens

    Amiens, France

  • CHU Besancon

    Besançon, France

  • CHU Bordeaux

    Bordeaux, France

  • CHU Caen

    Caen, France

  • CHU Clermont-Ferrand

    Clermont-Ferrand, 63000, France

  • CHU Dijon

    Dijon, France

  • CHU Fort-de-France

    Fort-de-France, Martinique

  • CHU Grenoble

    Grenoble, France

  • CHU Lille

    Lille, France

  • CHU Limoges

    Limoges, France

  • CHU Montpellier

    Montpellier, France

  • CHU Nancy

    Nancy, France

  • CHU Nantes

    Nantes, France

  • CHU Nice

    Nice, France

  • CHU Nîmes

    Nîmes, France

  • CHU Poitiers

    Poitiers, France

  • CHU Rennes

    Rennes, France

  • CHU Strasbourg

    Strasbourg, France

  • CHU Toulouse

    Toulouse, France

  • CHU Tours

    Tours, France

  • Hospices Civils de Lyon

    Lyon, France

  • Hôpital Fondation Rothschild

    Paris, France

  • Hôpital Saint Antoine

    Paris, France

  • Hôpital de la Pitié-Salpêtrière

    Paris, France

More trials for these conditions

Other studies related to the condition(s) this trial covers.